Breaking News

Movetis advised by Eubelius in respect of public tender offer by Shire

tesa — Mon, 16 Aug 2010 10:58:18 +0200

Breaking news datum

03/08/2010

Breaking news tekst

Movetis NV, the European specialty pharmaceutical company focused on the discovery, development and commercialisation of drugs for the treatment of diseases in the GI area, on 3 August 2010 received a conditional offer from a Luxembourg wholly-owned subsidiary of Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, to acquire all outstanding shares and warrants of Movetis NV at an offer price of EUR 19.00 in cash per share, valuing the Company’s equity, on a fully diluted basis, at EUR 428 million.

The shares of Movetis are admitted to trading on Euronext Brussels.

The Eubelius team advising Movetis in respect of the public tender offer by Shire is led by Lars Van Bever and Matthias Wauters.

Eubelius received Silver Award "Best Benelux Law Firm" at 2010 International Legal Alliance Summit

tesa — Thu, 24 Jun 2010 16:49:48 +0200

Breaking news datum

03/06/2010

Breaking news tekst

At its ceremony in Paris on 3 June 2010, the I.L.A Summit and Award presented Eubelius with a Silver Award for the Best Benelux Law Firm. The nomination was based on the suggestions made by the jury and international ranking.

Eubelius participates in 20 km of Brussels run

tesa — Mon, 31 May 2010 11:58:32 +0200

Breaking news datum

31/05/2010

Breaking news tekst

For a number of years now, some law firms have been actively participating in the annual Brussels 20km run which takes place in Brussels on a Sunday end May, and Eubelius is no exception.

Our team consisting of 28 runners ran the Brussels 20km under the umbrella of "Legal Run" whose goal is to raise money for a chosen charity.

Eubelius encourages its lawyers and staff to stay fit to better serve our clients, in line with our motto ALWAYS AT YOUR SERVICE;

Photos:

vestry — Tue, 10 Nov 2009 14:43:15 +0100

Breaking news datum

24/02/2010

Movetis, advised by Eubelius, successfully completes EUR 97.75 Mio IPO on Euronext Brussels

vestry — Tue, 12 Jan 2010 14:17:49 +0100

Breaking news datum

11/01/2010

Breaking news tekst

Movetis NV, a European specialty pharmaceutical company focused on the commercialisation, discovery and development of drugs for the treatment of diseases in the GI area, on 8 December 2009 successfully completed its Initial Public Offering (IPO) raising the targeted €85 million. The offering consisted of a public offering in Belgium and a private placement to institutional investors elsewhere outside the US. As the over-allotment option has been exercised in full, the total amount of the capital increase amounts to €97.75 million.
The shares of Movetis have been admitted to trading on Euronext Brussels. Movetis' IPO is the first IPO by a European pharma/biotech company since early 2008.
The Eubelius team advising Movetis on its IPO was led by Lars Van Bever, Erwin Destuyver and Michael Truyen.

Eubelius privileged partner of the Belgian Institute for company lawyers in 2010

vestry — Thu, 17 Dec 2009 15:13:05 +0100

Breaking news datum

17/12/2009

Breaking news tekst

Eubelius is happy and proud to be the privileged partner of the Belgian Institute for company lawyers (IBJ/IJE) in 2010.
Eubelius will propose together with the Institute a programme of varied seminars to all members of the Institute and will collaborate upon invitation of the Institute with a series of its activities.
All partners and associates of Eubelius are looking forward to this privileged partnership.
A detailed programme of the activities will follow.

WDP, advised by Eubelius, successfully completes EUR 73.5 Mio Rights Issue

Bea Persoons — Mon, 06 Jul 2009 15:16:14 +0200

Breaking news datum

06/07/2009

Breaking news tekst

Warehouses De Pauw ("WDP"), a real-estate investment company (sicafi) specialized in semi-industrial and logistics property and listed on Euronext Brussels and Euronext Paris, on 30 June 2009 successfully completed a capital increase by way of a public offering with preferential rights for an amount of EUR 73,500,000.

During the first phase, 94.15% of the offered shares were subscribed for by way of exercise of preferential subscription rights. The unexercised preferential rights were offered as scrips to institutional investors by way of an accelerated bookbuilt offering (ABO).

The new shares were admitted to trading on Euronext Brussels and Euronext Paris on 30 June 2009.

The Eubelius team advising WDP on this transaction was led by Lars Van Bever, Erwin Destuyver and Michael Truyen.

Eubelius supports the Women In Law (WIL) Programme

vestry — Tue, 03 Feb 2009 15:35:44 +0100

Breaking news datum

03/02/2009

Breaking news tekst

There are at least as many women finding their way to law school and to the bar as there are men. But, in spite of this equal starting point, it appears that the number of women remaining at the bar after five to eight years steadily decreases, and women tend to disappear from the profession altogether higher up in the hierarchy of law firms.

Eleven renowned law firms, amongst which Eubelius, have decided to unite their strengths to tackle this problem by encouraging and supporting promising young women to build their careers within law firms.

More information & programme

Eubelius wishes you a Happy New Year

vestry — Fri, 21 Dec 2007 08:51:28 +0100

Breaking news datum

23/12/2008

Breaking news tekst

Eubelius wishes you a Happy New Year
The savings that result from the electronic distribution of our season's greetings are donated to charity

View our e-card here

Belgacom/Scarlet deal cleared in second phase investigation

vestry — Mon, 17 Nov 2008 11:56:26 +0100

Breaking news datum

17/11/2008

Breaking news tekst

The Belgian Competition Council on 7 November 2008 granted second phase clearance of the acquisition by Belgacom NV/SA of Scarlet N.V. The acquisition was hotly contested by almost all of Belgacom's competitors. Competition clearance eventually was obtained on the basis of detailed and innovative commitments offered by Belgacom and accepted by the Competition Council after a market test. Eubelius served as counsel to Belgacom. The Eubelius team that worked on the merger clearance application consisted of Hans Gilliams, Jan Bocken, Koen Baekelandt and Michael Vansteenbeeck.